(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CLINICAL DOSE OPTIMIZATION SERVICE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

CLINICAL DOSE OPTIMIZATION SERVICE

ST13

US500000086901655

Class

42, 44

Filing

86901655

Registration

5403544

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

48

Latest update

09/10/2024

Trademark type

Word

Nice classes

42, 44

Filing date

02/09/2016

Registration date

02/13/2018

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/10/2024

Last transaction

09/10/2024

Responsible office

United States Patent and Trademark Office

Status code

701

Official register

Supplemental Register

First use anywhere

11/29/2015

First use in commerce

11/29/2015

Drawing code

4

Owner type

03

Owner location

Glenwood, IL, US

Examiner

SAUNDERS, ANDREA DAWN

Current location

Historical data usage

Holders and representatives

Holders

Landauer, Inc.

Representatives

Caldwell A. Camero Fluke Corporation

Technical classification

Nice Classes

Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Analyzing patient radiation dose data and preparing scientific reports providing information on optimizing imaging protocols by comparing dose performance to external benchmarks for dosimetry monitoring purposes; Analyzing patient radiation dose data and preparing scientific reports providing information on incidents where a patient dose index exceeds expected dose index ranges for dosimetry monitoring purposes; Analyzing computed tomography protocols and preparing scientific reports providing information on optimizing imaging protocols by comparing radiation dose performance to external benchmarks for medical purposes; Analyzing computed tomography protocols and preparing scientific reports providing information on incidents where a patient radiation dose index exceeds expected dose index ranges for dosimetry monitoring purposes; Consulting services in the field of monitoring the proper control and handling of radiation material to identify options for reducing radiation dosage as part of medical treatment; Consulting services in the field of radiation monitoring to optimize the radiation dose delivered to patients while preserving image clarity for optimal clinical decision making for dosimetry monitoring; Monitoring and benchmarking of radiation dose alerts for dosimetry monitoring

Class 44

Consulting services in the field of medical imaging regarding the use and operation of computed tomography and fluoroscopy; Providing informationadvice and data on medical imaging; Consulting services in the field of radiation monitoring to optimize the radiation dose delivered to patients while preserving image clarity for optimal clinical decision making for medical dosimetry

Publications

History of USPTO decisions and trademark events.

48 publications found

NAS8

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

09/10/2024

8.OK

REGISTERED - SEC. 8 (6-YR) ACCEPTED

09/10/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

09/09/2024

ES8R

TEAS SECTION 8 RECEIVED

02/13/2024

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

02/13/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

03/26/2021

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

03/26/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

03/26/2021

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

03/26/2021

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

03/26/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

05/09/2018

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

05/09/2018

R.SR

REGISTERED-SUPPLEMENTAL REGISTER

02/13/2018

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

01/08/2018

ALIE

ASSIGNED TO LIE

12/26/2017

CNTA

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

12/12/2017

XAEC

EXAMINER'S AMENDMENT ENTERED

12/12/2017

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

12/12/2017

GNEA

EXAMINERS AMENDMENT E-MAILED

12/12/2017

CNEA

EXAMINERS AMENDMENT -WRITTEN

12/12/2017

ZZAX

PREVIOUS ALLOWANCE WITHDRAWN-TIMELY AAU

12/05/2017

CNTA

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

12/05/2017

XAEC

EXAMINER'S AMENDMENT ENTERED

12/05/2017

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

12/05/2017

GNEA

EXAMINERS AMENDMENT E-MAILED

12/05/2017

CNEA

EXAMINERS AMENDMENT -WRITTEN

12/05/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/23/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/22/2017

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/22/2017

GPRN

NOTIFICATION OF PRIORITY ACTION E-MAILED

05/23/2017

GPRA

PRIORITY ACTION E-MAILED

05/23/2017

CPRA

PRIORITY ACTION WRITTEN

05/23/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/26/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/26/2017

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

04/26/2017

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

12/01/2016

GNFR

FINAL REFUSAL E-MAILED

12/01/2016

CNFR

FINAL REFUSAL WRITTEN

12/01/2016

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/15/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/14/2016

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/14/2016

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

05/12/2016

GNRT

NON-FINAL ACTION E-MAILED

05/12/2016

CNRT

NON-FINAL ACTION WRITTEN

05/12/2016

DOCK

ASSIGNED TO EXAMINER

05/12/2016

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

04/12/2016

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/13/2016

NWAP

NEW APPLICATION ENTERED

02/12/2016

Continuous trademark protection

Get notified about every new filing that threatens CLINICAL DOSE OPTIMIZATION SERVICE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.